Spinal meningioma

• The role of nuclear medicine in central nervous system evaluation
• Advancing Neurosurgical Oncology and AI Innovations in Latin American Brain Cancer Care: Insights from a Center of Excellence
• Comparative analysis of transformer-based deep learning models for glioma and meningioma classification
• Investigation of the frequency of meningothelial hyperplasia and its clinicopathological correlation in patients diagnosed with subdural hematoma
• Contraception and neurological diseases
• Cranioplasty After Removal of a Meningioma With Skull Invasion: A Technical Case Report
• Massive Foramen Magnum Meningioma Mimicking a Stroke
• Diarylpentanoid, a curcumin analog, inhibits malignant meningioma growth in both in vitro and in vivo models

Spinal meningioma epidemiology.

Spinal meningioma classification.

Most spinal meningiomas are benign, with greater than 95% being classified as WHO grade I lesions, although clear cell meningiomas (a WHO grade II histological variant) have a predilection for the spine.

They are believed to originate from the denticulate ligaments.

The majority of patients present with motor impairments as a result of compression of the spinal cord. Less common presentations include sensory deficits, pain and sphincter dysfunction.

see Spinal meningioma diagnosis.

see Spinal meningioma differential diagnosis.

see Spinal meningioma treatment.

see Spinal meningioma outcome.

Spinal meningioma Meta-analysis.

see Spinal meningioma case series.

see Spinal meningioma case reports.